No patients were excluded for any other reason, including past medical cannabis usage, indication for medical cannabis or benzodiazepines, previous discontinuation, or any observable characteristics.
Discussion Patients initiated on medical cannabis therapy showed significant benzodiazepine discontinuation rates after their first follow-up visit to their medical cannabis prescriber, and continued to show significant discontinuation rates thereafter.
The observed association between medical cannabis use and benzodiazepine discontinuation should not be misinterpreted as causative, and these results do not support inferences about substitution of medical cannabis for benzodiazepine therapy.
Lucas P, Walsh Z. Medical cannabis access, use, and substitution for prescription opioids and other substances: a survey of authorized medical cannabis patients.
Read more here: https://www.liebertpub.com/doi/10.1089/can.2018.0020